Simulations Plus, Inc. (NASDAQ:SLP) Shares Purchased by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC increased its stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 15.9% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 106,082 shares of the technology company's stock after acquiring an additional 14,582 shares during the quarter. Rice Hall James & Associates LLC owned approximately 0.53% of Simulations Plus worth $2,601,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp raised its stake in Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after purchasing an additional 427 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Simulations Plus by 33.8% during the first quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock worth $36,000 after buying an additional 375 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Simulations Plus in the fourth quarter valued at about $39,000. Tower Research Capital LLC TRC raised its position in shares of Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock valued at $72,000 after buying an additional 764 shares during the last quarter. Finally, AlphaQuest LLC lifted its stake in shares of Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock worth $75,000 after buying an additional 2,243 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the completion of the transaction, the director directly owned 3,344,157 shares in the company, valued at approximately $112,062,701.07. This represents a 0.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 19.40% of the stock is currently owned by company insiders.

Simulations Plus Stock Down 0.5%

NASDAQ:SLP traded down $0.06 on Wednesday, hitting $12.91. The stock had a trading volume of 1,670,727 shares, compared to its average volume of 299,690. The company has a fifty day moving average price of $23.80 and a two-hundred day moving average price of $28.08. Simulations Plus, Inc. has a 1-year low of $12.86 and a 1-year high of $44.27. The stock has a market cap of $259.62 million, a price-to-earnings ratio of -4.10 and a beta of 0.83.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings results on Monday, July 14th. The technology company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.26 by $0.19. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 10.65%. The firm had revenue of $20.36 million for the quarter, compared to analyst estimates of $22.83 million. During the same quarter in the previous year, the company earned $0.27 EPS. The business's revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, analysts anticipate that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on SLP shares. Craig Hallum dropped their price objective on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating for the company in a research note on Friday, June 13th. William Blair restated an "outperform" rating on shares of Simulations Plus in a report on Tuesday. Wall Street Zen upgraded Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Stephens reduced their price objective on Simulations Plus from $28.00 to $20.00 and set an "overweight" rating on the stock in a research report on Tuesday. Finally, BTIG Research lowered their price objective on Simulations Plus from $41.00 to $25.00 and set a "buy" rating on the stock in a research note on Monday, July 7th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $26.50.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.